PREDICTIVE VALUE OF CIRCULATING ENDOTHELIAL CELL (CEC) LEVELS IN METASTATIC OR LOCALLY ADVANCED NEUROENDOCRINE DIGESTIVE TUMOR PATIENTS TREATED WITH CHEMOTHERAPY AND BEVACIZUMAB

被引:0
|
作者
Farace, F. F. [1 ]
Lombard-Bohas, C. [2 ]
Mitry, E. [3 ]
Ychou, M. [4 ]
Bengrine-Lefevre, L. [5 ]
Lecomte, T. [6 ]
Joly, K. [7 ]
Ducreux, M. [8 ]
Baudin, E.
机构
[1] Inst Gustave Roussy, Lab Translat Res, Villejuif, France
[2] Hosp Civils Lyon, Hop Edouard Herriot, Lyon, France
[3] Inst Curie, Paris, France
[4] Ctr Val dAurelle, Montpellier, France
[5] Hop St Antoine, F-75571 Paris, France
[6] Hop Trousseau, Tours, France
[7] Roche Biomed Labs, Boulogne Billancourt, France
[8] Inst Cancerol Gustave Roussy, Villejuif, France
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:85 / 85
页数:1
相关论文
共 50 条
  • [21] Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma
    Voog, E
    Biron, P
    Martin, JP
    Blay, JY
    CANCER, 1999, 85 (12) : 2589 - 2595
  • [22] Predictive value of angiogenic proteins in patients with metastatic melanoma treated with bevacizumab monotherapy
    Schuster, Cornelia
    Akslen, Lars A.
    Stokowy, Tomasz
    Straume, Oddbjorn
    JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 2019, 5 (01): : 53 - 62
  • [23] Aneuploid Circulating Endothelial Cells with Prognostic Value in Locally Advanced Breast Cancer Patients After Neoadjuvant Chemotherapy
    Li, Minghui
    Liu, Yuelin
    Han, Xu
    Li, Tao
    Zhang, Zhizheng
    Xue, Ningyi
    Liang, Mengdi
    Ma, Ge
    Xia, Tiansong
    BREAST CANCER-TARGETS AND THERAPY, 2024, 16 : 761 - 768
  • [24] Exploring the prognostic and predictive value of circulating tumor DNA in patients with advanced colorectal cancer and chemotherapy.
    Liu, Xiu
    Zhang, Xuan
    Ou, Kai
    Lu, Chelong
    Zheng, Dong
    Liu, Jun
    Xu, Qiang
    Yang, Lin
    CANCER RESEARCH, 2021, 81 (13)
  • [25] Bevacizumab in patients (pts) with advanced hepatocellular carcinoma (HCC): Preliminary results of a phase II study with circulating endothelial cell (CEC) monitoring
    Malka, D.
    Dromain, C.
    Farace, F.
    Horn, S.
    Pignon, J.
    Ducreux, M.
    Boige, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [26] Predictive value of circulating tumor DNA in locally advanced rectal cancer patients receiving neoadjuvant radiochemotherapy.
    Li, Min
    Xiao, WeiWei
    Zhao, Grace Q.
    Guo, Zhiwei
    Yang, Xuexi
    Lin, Shengrong
    Ying, Kang
    Li, Ming
    Gao, Yuan -Hong
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [27] Predictive value of VEGF gene polymorphisms in metastatic colorectal cancer patients treated with a bevacizumab-based chemotherapy.
    Ulivi, Paola
    Marisi, Giorgia
    Scarpi, Emanuela
    Passardi, Alessandro
    Ragazzini, Angela
    Frassineti, Giovanni Luca
    Zoli, Wainer
    Valgiusti, Martina
    Nanni, Oriana
    Calistri, Daniele
    Casacci, Fabio
    Amadori, Dino
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [28] Predictive value of survivin alternative transcript expression in locally advanced breast cancer patients treated with neoadjuvant chemotherapy
    Boidot, Romain
    Vegran, Frederique
    Lizard-Nacol, Sarab
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2009, 23 (02) : 285 - 291
  • [29] Prognostic Value of Circulating Tumor Cells and Circulating Tumor Microemboli in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy
    Zhang, J.
    Wan, J.
    Wang, Y.
    Shen, L.
    Zhang, H.
    Zhu, J.
    Zhang, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E589 - E589
  • [30] Circulating tumor cell analysis in locally advanced and metastatic squamous cell carcinoma of the head and neck
    Harris, Ethan J.
    Huang, Julian
    Carroll, Erin
    Lowe, Alarice C.
    Chau, Nicole G.
    Rabinowits, Guilherme
    Haddad, Robert
    Hanna, Glenn J.
    Haddad, Tyler
    Sanborn, Matthew
    Kacew, Alec
    Lorch, Jochen
    LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY, 2020, 5 (06): : 1063 - 1069